We serve Chemical Name:2-Propylpiperidine hydrochloride CAS:51541-42-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Propylpiperidine hydrochloride
CAS.NO:51541-42-5
Synonyms:dl-coniin hydrochloride;dl-cicutine hydrochloride;2-propylpiperidine hcl;(+/-)-2-propylpiperidine hydrochloride;dl-coniine hydrochloride;coniine,dl-hcl;dl-coniine hcl
Molecular Formula:C8H18ClN
Molecular Weight:163.68800
HS Code:
Physical and Chemical Properties:
Melting point:-210ºC(lit.)
Boiling point:166.2ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:12.03000
Exact Mass:163.11300
LogP:3.05940
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like dl-coniin hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dl-coniine hcl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,coniine,dl-hcl Use and application,coniine,dl-hcl technical grade,usp/ep/jp grade.
Related News: Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days. 2-Propylpiperidine hydrochloride manufacturer ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� 2-Propylpiperidine hydrochloride supplier Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days. 2-Propylpiperidine hydrochloride vendor Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. 2-Propylpiperidine hydrochloride factory The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.”